Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

Cardiovascular disease and lipids. Issues and evidence for the management of dyslipidaemia in primary care.

The commonest manifestations of cardiovascular disease, namely coronary heart disease (CHD) and stroke, represent the two most common causes of death in the world today. Furthermore, cardiovascular diseases have the highest healthcare utilisation costs in most countries. Both primary and secondary p...

Fuld beskrivelse

Bibliografiske detaljer
Hovedforfatter:	Hobbs, F
Format:	Journal article
Sprog:	English
Udgivet:	2003

Lignende værker

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
af: article Editorial
Udgivet: (2020-09-01)

Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.
af: Hobbs, R, et al.
Udgivet: (2005)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
af: Alberto J Lorenzatti, et al.
Udgivet: (2020-02-01)

2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
af: Mach, F, et al.
Udgivet: (2019)

Biochemical effects of statins on lipid parameters among newly diagnosed dyslipidaemia subjects in primary care
af: Meor Anuar Shuhaili, Meor Fairuz Rizal, et al.
Udgivet: (2018)

Seasonal variation lipid levels in the patients with dyslipidaemia
af: I V Radysh, et al.
Udgivet: (2009-12-01)

Cardiovascular risk management in primary care.
af: Hobbs, F
Udgivet: (2002)

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
af: Francois Mach, et al.
Udgivet: (2020-06-01)

Dyslipidaemia—Genotype Interactions with Nutrient Intake and Cerebro-Cardiovascular Disease
af: Sung-Bum Lee, et al.
Udgivet: (2022-07-01)

Current insights on dyslipidaemia management for prevention of atherosclerotic cardiovascular disease: a malaysian perspective
af: Wan Ahmad, Wan Azman, et al.
Udgivet: (2023)

Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
af: M R Essop, et al.
Udgivet: (2023-11-01)

Managing dyslipidaemia in patients with chronic kidney disease
af: Ashwani Mehta
Udgivet: (2024-03-01)

Paraoxonase 1 concerning dyslipidaemia, cardiovascular diseases, and mortality in haemodialysis patients
af: Alicja E. Grzegorzewska, et al.
Udgivet: (2021-03-01)

Serum zinc levels in diabetic patients with and without dyslipidaemia and cardiovascular diseases
af: Lakmal Jayaweera, et al.
Udgivet: (2020-08-01)

Role of dyslipidaemia and lipid peroxidation in pregnancy induced hypertension
af: Saxena S, et al.
Udgivet: (2015-07-01)

New concepts in the management of dyslipidaemia
af: Baris Gencer, et al.
Udgivet: (2016-11-01)

Managing dyslipidaemia in young adults
af: Jamshed J. Dalal, et al.
Udgivet: (2024-03-01)

Role of statins in the management of dyslipidaemia
af: Saumitra Ray
Udgivet: (2024-03-01)

The changing paradigm of dyslipidaemia management
af: Ruvan Ekanayaka
Udgivet: (2017-04-01)

Update on the Management of Diabetic Dyslipidaemia
af: Iciar Martín-Timón, et al.
Udgivet: (2018-11-01)

The scale of heart failure: diagnosis and management issues for primary care.
af: Hobbs, F
Udgivet: (1999)

Primary prevention of cardiovascular disease: managing hypertension and hyperlipidaemia.
af: Hobbs, F
Udgivet: (2004)

Red yeast rice for dyslipidaemias and cardiovascular risk reduction: A position paper of the International Lipid Expert Panel
af: Maciej Banach, et al.
Udgivet: (2022-09-01)

Non- high-density lipoprotein cholesterol and cardiovascular disease in patients with diabetic dyslipidaemia
af: Alberto Zambon
Udgivet: (2020-04-01)

The changes of immunoglobulin G N-glycosylation in blood lipids and dyslipidaemia
af: Di Liu, et al.
Udgivet: (2018-08-01)

Emerging Strategies for the Management of Atherogenic Dyslipidaemia
af: Anandita Agarwala, et al.
Udgivet: (2020-02-01)

Established and Emerging Approaches for the Management of Dyslipidaemia
af: Giuseppe Danilo Norata
Udgivet: (2012-01-01)

Secondary dyslipidaemia
af: D.J. Blom
Udgivet: (2011-07-01)

Diabetic dyslipidaemia
af: Subashini C. Thambiah, et al.
Udgivet: (2021-08-01)

Obstructive Sleep Apnoea and Lipid Metabolism: The Summary of Evidence and Future Perspectives in the Pathophysiology of OSA-Associated Dyslipidaemia
af: Martina Meszaros, et al.
Udgivet: (2022-10-01)

Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.
af: Erhardt, L, et al.
Udgivet: (2008)

Effectiveness of an audit programme for dyslipidaemia management in a primary care setting in Macau: a quality improvement study
af: In Wong, et al.
Udgivet: (2020-01-01)

Optimisation of lipids for prevention of cardiovascular disease in a primary care
af: Smita Bakhai, et al.
Udgivet: (2018-07-01)

Role of PCSK9 inhibitors in the management of dyslipidaemia
af: Tiny Nair
Udgivet: (2024-03-01)

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
af: Alberico L. Catapano, et al.
Udgivet: (2017-06-01)

Trends in prevalence of dyslipidaemias and the risk of mortality in Lithuanian urban population aged 45-64 in relation to the presence of the dyslipidaemias and the other cardiovascular risk factors.
af: Dalia Luksiene, et al.
Udgivet: (2014-01-01)

Dyslipidaemia and inflammatory markers as the risk predictors for cardiovascular disease in newly diagnosed premenopausal hypothyroid women
af: Balamurugan Vaideki, et al.
Udgivet: (2023-01-01)

Dyslipidaemia in endocrine disorders
af: Kalyani Sridharan, et al.
Udgivet: (2024-03-01)

Treatment of Dyslipidaemia in Children
af: Riccardo Fiorentino, et al.
Udgivet: (2021-08-01)

Dyslipidaemia in Sri Lanka
af: Anne Thushara Matthias, et al.
Udgivet: (2022-01-01)